Nautilus Biotechnology (NASDAQ:NAUT) executives outlined the company’s strategy to “unlock the power of the proteome” and ...

Pluri Inc. ('Pluri” or the 'Company”) (Nasdaq, TASE: PLUR), a biotechnology company leveraging a proprietary cell-based ...

A new biosensor developed at the Department of Energy's Oak Ridge National Laboratory detects the emerging presence of fungus ...

The Shift from Chemistry to Biological FactoriesHow Digital Code is Replacing Synthetic ChemicalsAs soon as early scientists ...

Researchers have built a series of CRISPR-based platforms that can switch endogenous genes on and, just as critically, dial ...

India is stepping up efforts to explore critical minerals, promote startups in mining and build strong domestic supply chains ...

Countless scientists and at least a dozen high-concept sci-fi comedies over the past 30 years have speculated on the ...

Q4 2025 earnings call: commercialization shift, new recombinant product launches, partners, 2026 revenue outlook & cash runway.

Stronger oversight needed as unchecked AI risks undermining jobs and data security, government advisers urge at the Boao ...

Healthcare is shifting from reactive care to predictive, personalized prevention, using data to act earlier and improve ...

Spread the loveIn the rapidly evolving field of biotechnology, longevity investing has gained significant traction among investors and researchers alike. However, a new perspective is emerging that ...

(Nasdaq: NKTX), a clinical-stage biotechnology company developing engineered natural killer (NK) cell therapies to treat ...